Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Rituxan's sBLA receives a Complete Response from the FDA

Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.

19 Oct 2009

CytoSorb human clinical trials nearing completion

TapeBeat.com, the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth.

19 Oct 2009

Inaccurate body temperature readings can harm the entire health care system

As we head into a flu season where the 2009 H1N1 swine flu is expected to cause increased sickness, hospitalization and deaths across the U.S., something as simple as inaccurate body temperature measurements may lead to social and economic turmoil – and may cause many more deaths.

19 Oct 2009

Government closely monitors swine flu vaccine

The government is closely monitoring the safety of the new H1N1 swine flu vaccine amid people's concerns.

19 Oct 2009

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Covidien, a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, today announced the global launch of Mallinckrodt™ TaperGuard™ and TaperGuard™ Evac endotracheal tubes.

19 Oct 2009

Phase I clinical study of PENNVAX-B preventive DNA vaccine using electroporation technology

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, and the HIV Vaccine Trials Network (HVTN) announced today the initiation of a phase I clinical study of Inovio’s PENNVAX-B preventive DNA vaccine delivered using its proprietary electroporation technology.

19 Oct 2009

Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics

Delays in shipments from vaccine manufacturers will force the Aurora Visiting Nurse Association of Wisconsin to suspend its seasonal flu vaccination clinics throughout eastern Wisconsin.

19 Oct 2009

International human migration needs to be factored into infectious disease policy

When people travel, bacteria and other infectious agents travel with them. As about a billion people cross international borders each year, many more billions of the bugs come along for the ride.

19 Oct 2009

FDA urges consumers to exercise care on online H1N1 drug products

The U.S. Food and Drug Administration today warned consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus.

19 Oct 2009

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

Cannabis Science Inc., an emerging pharmaceutical cannabis company, notes a report by epidemiologists at the Centers for Disease Control and Prevention (CDC) saying that, among people hospitalized with severe cases of the pandemic strain of H1N1 Swine Flu, asthma is by far the most common underlying condition associated with he disease.

19 Oct 2009

CVS Caremark's seasonal flu shot clinics to run through October 22

CVS/pharmacy announced today that its seasonal flu shot clinics will run through October 22, in light of manufacturer delays in delivery of seasonal flu vaccine affecting all health care providers. However, MinuteClinic will continue to administer seasonal flu vaccines at its 500 locations in 25 states throughout the flu season with the supply of vaccine replenished as frequently as possible.

19 Oct 2009

Multi-million dollar cooperative agreement for SMA drug development program

Paratek Pharmaceuticals (Boston, MA) and Families of Spinal Muscular Atrophy (Elk Grove Village, IL) announced today that a jointly funded drug development program for Spinal Muscular Atrophy (SMA) has been awarded a multi-million dollar cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS).

19 Oct 2009

Breathe Right "Extra" to help consumers sleep better at night

While many of us will never know the feeling of playing in a professional football game, we all should know the feeling of getting a good night's sleep. However, many adults suffer from night-time congestion, a good night's sleep can be as elusive as a speedy running back - until now.

15 Oct 2009

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Baxter International Inc. today reported solid financial results for the third quarter of 2009, and provided its fourth quarter and updated full-year 2009 financial outlook.

From Baxter International Inc. 15 Oct 2009

European authorities approve Medivir’s marketing authorisation application in 14 European countries

The European regulatory authorities have now approved Medivir’s marketing authorisation application in 14 European countries. The trademark for the product in Europe will be XerclearTM.

15 Oct 2009

Pharma IQ reports on the 7th Annual Cold Chain Distribution for Pharmaceuticals conference

Pharma IQ, a division of IQPC, held the 7th Annual Cold Chain Distribution for Pharmaceuticals, September 21-24, 2009 at the Pennsylvania Convention Center in Philadelphia, PA (www.coldchainpharma.com). This industry-leading global forum gathered more than 350 pharmaceutical, regulatory and logistic experts to address the greatest challenges supply chain professionals face today.

From IQPC Ltd 15 Oct 2009

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.

15 Oct 2009

Survey reports patients' concern about the safety and access to flu vaccines

Although some parents may be lukewarm to the H1N1 vaccination, Lakeside Community Healthcare www.LakesideCommunityHealthcare.com, one of Southern California's largest integrated, comprehensive healthcare organizations, reports broader patient concern about both the safety of and access to the vaccine.

15 Oct 2009

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

BioTech Medics, Inc. announces that it has received independent clinical testing results of its SHBAN™ Hand Sanitizer Solution to prove SHBAN™ kills the H1N1 (Swine) Influenza A virus.

15 Oct 2009

UNICEF and WHO call for an urgent plan to control diarrheal disease

The United Nations Children’s Fund (UNICEF) and World Health Organization (WHO) released a joint report today demonstrating the urgent need to focus attention on diarrheal disease, a neglected illness responsible for the deaths of about 1.5 million children under 5 each year. This unacceptable loss of life can be stopped.

15 Oct 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Rituxan's sBLA receives a Complete Response from the FDA

CytoSorb human clinical trials nearing completion

Inaccurate body temperature readings can harm the entire health care system

Government closely monitors swine flu vaccine

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Phase I clinical study of PENNVAX-B preventive DNA vaccine using electroporation technology

Aurora Visiting Nurse Association to suspend its seasonal flu vaccination clinics

International human migration needs to be factored into infectious disease policy

FDA urges consumers to exercise care on online H1N1 drug products

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

CVS Caremark's seasonal flu shot clinics to run through October 22

Multi-million dollar cooperative agreement for SMA drug development program

Breathe Right "Extra" to help consumers sleep better at night

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

European authorities approve Medivir’s marketing authorisation application in 14 European countries

Pharma IQ reports on the 7th Annual Cold Chain Distribution for Pharmaceuticals conference

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

Survey reports patients' concern about the safety and access to flu vaccines

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

UNICEF and WHO call for an urgent plan to control diarrheal disease

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in